Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Practical Considerations for Implementing Immunoassays for Urine Drug Testing in Clinical LaboratoriesPractical Considerations for Implementing Targeted Mass Spectrometry for Urine Drug Testing in Clinical Laboratories
Untargeted Mass Spectrometry Applications for Clinical Toxicology
Advances in Chromatography-Free and Ambient Ionization Mass Spectrometry Techniques Toward Clinical Toxicology Testing
Point-of-Care Drug Testing
Automated Quality Assurance Rules for Liquid Chromatography-Mass Spectrometry Testing in a Clinical Laboratory
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels
Reflexive Drug Testing Strategies for Efficient Utilization of Resources and Better Interpretation
Interpreting Toxicology Results in Perinatal and Newborn Specimens: Urine, Meconium, and Umbilical Cord
Specimen Validity Testing in the Toxicology Laboratory
Detecting Xylazine: Prevalence, Pharmacokinetics, and Analytical Considerations
Detection of Fentanyl and Fentanyl Analogs
Testing Strategies and the Emergence of Designer Benzodiazepines
Recent Advances in Therapeutic Drug Monitoring of Antineoplastic and Antimicrobial Agents in Children
Optimizing Therapeutic Drug Monitoring of Anti-infectives: Patient and Clinical Setting Considerations
Pediatric Toxicology: Children Are Not Small Adults
Alcohol and Drug Testing in Motor Vehicle Crashes

